Walleye Trading
NYMX

Walleye Trading’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Walleye Trading’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-3,600
Closed -$13 – 5082
2017
Q1 		$13 Buy
+3,600
New +$11.8K ﹤0.01% 4273
2016
Q4 		– Sell
-1,200
Closed -$4K – 5321
2016
Q3 		$4K Sell
1,200
-2,700
-69% -$8.83K ﹤0.01% 4606
2016
Q2 		$13K Buy
+3,900
New +$9.58K ﹤0.01% 4746
2016
Q1 		– Sell
-8,800
Closed -$29K – 5968
2015
Q4 		$29K Buy
+8,800
New +$29.5K ﹤0.01% 4217

Other funds holding NYMX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Walleye Trading's NYMX Position: Q2 2017 in Review

Walleye Trading sold out of Nymox Pharmaceutical Corp (NYMX) in Q2 2017, closing a stake of 3,600 shares — an estimated $13 sold.

Walleye Trading first reported a position in NYMX in Q4 2015 and held it in 4 quarters. The position peaked at $29K in Q4 2015. 45 funds tracked by Wall St. Rank hold NYMX as of Q2 2017.

  • Walleye Trading reported no remaining Nymox Pharmaceutical Corp position as of Q2 2017 after selling out during the quarter.
  • Walleye Trading sold 3,600 Nymox Pharmaceutical Corp shares in Q2 2017, an estimated $13.
  • Walleye Trading first reported a position in Nymox Pharmaceutical Corp in Q4 2015 and held it in 4 quarters.
  • Walleye Trading's Nymox Pharmaceutical Corp position peaked at $29K in Q4 2015.
  • 45 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q2 2017.

Based on Walleye Trading's 13F filing for Q2 2017, filed 14 Aug 2017.